Latest News and Press Releases

Bemærk venligst, at rapporten udelukkende findes på engelsk ALK delivers Q3 sales growth of 20%, with tablet sales up 41% (unaudited) ALK’s revenue grew strongly during Q3 following broad-based...

ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) offentliggør delårsrapport for de første ni måneder (Q3) 2021 torsdag den 11. november 2021. ALK afholder samme dag kl. 13.30 (CET) en telefonkonference...

On Thursday, 11 November 2021, ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) releases its nine-month interim report (Q3) 2021. ALK will host a meeting for analysts and institutional investors that day...

ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) indberetter hermed følgende transaktioner: 1.Nærmere oplysninger om personen med ledelsesansvar/personen med nær tilknytning til dennea)NavnBertil...

ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) reports the following transactions: 1.Details of the person discharging managerial responsibility / person closely associateda)NameBertil Lindmark2.Reason...

Bemærk venligst, at rapporten udelukkende findes på engelsk ALK reports revenue up 13% with sales growth across its portfolio, outlook updated (unaudited) ALK’s revenue growth increased during Q2 on...

ALK reports revenue up 13% with sales growth across its portfolio, outlook updated (unaudited) ALK’s revenue growth increased during Q2 on continued strong momentum for tablet sales and a recovery in...

ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) meddeler i dag, at selskabet opjusterer forventningerne til regnskabsåret 2021, især til stigende indtjening, for at afspejle et bedre salgsforecast samt...

ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) today announced that the company is upgrading its full-year financial outlook especially with regards to increasing earnings to reflect an improved sales...

The Board of Directors of ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) is to nominate the former head of Consumer Healthcare at Sanofi, Alan Main, as an independent member of the Board of ALK-Abelló...